1 Day DRUG 0.90% DJIA 0.31% Russell 2K 0.21% Health Care/Life Sciences -1.12% ...
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
Donald Trump and biotech stocks joined the top 10. Bright Minds Biosciences Inc (NASDAQ:DRUG) shares are trading higher again after soaring last week. The company on Monday announced a new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback